Zaitsev, A.V.; Malkin, S.L.; Postnikova, T.Y.; Smolensky, I.V.; Zubareva, O.E.; Romanova, I.V.; Zakharova, M.V.; Karyakin, V.B.; Zavyalov, V.
Ceftriaxone Treatment Affects EAAT2 Expression and Glutamatergic Neurotransmission and Exerts a Weak Anticonvulsant Effect in Young Rats. Int. J. Mol. Sci. 2019, 20, 5852.
https://doi.org/10.3390/ijms20235852
AMA Style
Zaitsev AV, Malkin SL, Postnikova TY, Smolensky IV, Zubareva OE, Romanova IV, Zakharova MV, Karyakin VB, Zavyalov V.
Ceftriaxone Treatment Affects EAAT2 Expression and Glutamatergic Neurotransmission and Exerts a Weak Anticonvulsant Effect in Young Rats. International Journal of Molecular Sciences. 2019; 20(23):5852.
https://doi.org/10.3390/ijms20235852
Chicago/Turabian Style
Zaitsev, Aleksey V., Sergey L. Malkin, Tatyana Y. Postnikova, Ilya V. Smolensky, Olga E. Zubareva, Irina V. Romanova, Maria V. Zakharova, Vladimir B. Karyakin, and Vladimir Zavyalov.
2019. "Ceftriaxone Treatment Affects EAAT2 Expression and Glutamatergic Neurotransmission and Exerts a Weak Anticonvulsant Effect in Young Rats" International Journal of Molecular Sciences 20, no. 23: 5852.
https://doi.org/10.3390/ijms20235852
APA Style
Zaitsev, A. V., Malkin, S. L., Postnikova, T. Y., Smolensky, I. V., Zubareva, O. E., Romanova, I. V., Zakharova, M. V., Karyakin, V. B., & Zavyalov, V.
(2019). Ceftriaxone Treatment Affects EAAT2 Expression and Glutamatergic Neurotransmission and Exerts a Weak Anticonvulsant Effect in Young Rats. International Journal of Molecular Sciences, 20(23), 5852.
https://doi.org/10.3390/ijms20235852